Cargando…
Helicobacter pylori and non-steroidal anti-inflammatory drugs: does infection affect the outcome of NSAID therapy?
1. H. pylori gastritis appears to increase the likelihood of developing dyspeptic symptoms on NSAID therapy. 2. There is preliminary evidence that the histologic severity of H. pylori gastritis may be adversely affected by NSAID therapy, with a consequent increase in the risk of developing a peptic...
Autor principal: | McCarthy, D. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yale Journal of Biology and Medicine
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2578884/ https://www.ncbi.nlm.nih.gov/pubmed/10378355 |
Ejemplares similares
-
Treatment with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Does Not Affect Outcome in Patients with Acute Myocarditis or Myopericarditis
por: Mirna, Moritz, et al.
Publicado: (2022) -
Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19
por: Bruce, Eilidh, et al.
Publicado: (2020) -
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19
por: Kushner, Pamela, et al.
Publicado: (2022) -
Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review
por: Sohail, Rohab, et al.
Publicado: (2023) -
Crystal structure of the non-steroidal anti-inflammatory drug (NSAID) tolmetin sodium
por: Konovalova, Irina S., et al.
Publicado: (2021)